We're Upgrading! We're excited to announce that Contract Laboratory is moving to a new and improved platform. Stay tuned!
  • Contact Us
  • |
  • Login
  • |
  • Create Account
Contract Laboratory Outsouring and Scientific Product Sourcing Network
  • Need Lab Testing or Scientific Research?

    Submit a Lab Request
  • How It Works
    Requesting Testing or Services Providing Testing or Services
  • |
  • Laboratory Requests
Laboratory Requests
How It Works

Need Lab Testing or Scientific Research?

Submit Lab Requests
  • Contact Us
  • |
  • Login
  • |
  • Create Account
  1. Laboratory News Center
  2. Laboratory Press Releases
  3. Standard Supports Drug Development

Standard Supports Drug Development

Apr 17, 2019

Drug manufacturers will be able to use a new ASTM International nanotechnology standard to help ensure quality control when developing drugs, including some that have the potential to be less toxic and more targeted. ASTM International's nanotechnology committee (E56) created the new standard (E3143).

?Nanotechnology offers great promise for new drugs to treat a wide variety of illnesses,? says ASTM International member Debra Kaiser, senior advisor, office of data and informatics, National Institute of Standards and Technology. ?This standard will be used to advance the development of liposome nanomaterials, the largest class of nanomaterial-based drug products.?

Kaiser explains that the new standard provides a recipe for determining the structure of a liposome nanomaterial. Liposome sacs are used as drug carriers that reduce toxicity and change the way the drug is distributed in the body.

According to Kaiser, using the new standard will reduce the documentation needed when a manufacturer submits a potential new product to a regulatory body, such as the U.S. Food and Drug Administration, which may reduce review time for the submission.

The committee welcomes participation in the development of its standards. Kaiser notes that the committee is planning new standards that help quantify the composition of liposomal drug formulations by various methods and in vitro immunotoxicology assays. Become a member of ASTM. The next meeting of ASTM International's nanotechnology committee is May 13-14 in Denver, Colorado, USA.

To purchase standards, contact ASTM International customer relations (tel +1.877.909.ASTM; sales@astm.org).

Links:

https://www.astm.org/newsroom/new-standard-will-help-oil-spill-prediction-cleanup

  • Laboratory News Center
  • Press Releases
  • Events
  • Articles
  • Case Studies
  • White Papers
  • Laboratory Outsourcing e-magazine
Submit Laboratory News

Need Laboratories for Scientific Research, Testing, Inspection, or Certification?

Save time and money. Find labs for all your projects quickly and easily!

Submit Laboratory Requests

POPULAR LABORATORY INDUSTRIES SERVICES AND SOLUTIONS

Advanced Technology Aerospace and Aviation Automotive and Vehicle Agriculture and Farming Apparel and Footwear Biotechnology Chemicals Construction and Building Cosmetics and Beauty
Consumer Products Dietary Supplements Electronics Environment and Ecology Food and Beverages Healthcare and Medical Hygiene and Personal Care Industrial Information Technology
Manufacturing and Production Marijuana, Hemp and Cannabis Medical Devices Metals Mining and Ores Oil and Petroleum Packages and Packaging
Pharmaceutical Plastics and Polymers Power and Energy Recycling and Recyclables Sports and Sporting Goods Telecommunications Transportation Wood, Paper and Pulp

Corporate
About Advertising Press Room Partners
Laboratory Requests
Test Requests Service Requests Product Requests Business Requests
Laboratory Resources
Laboratory Directory Laboratory News Laboratory Events Outsource! e-magazine
Help and Support
Contact Us FAQ

Follow us. We're Social.

Facebook LinkedIn Twitter Instagram

Contract Laboratory values your privacy. For more information please view our Privacy Policy
Policy for use of Generative Artificial Intelligence in our Editorial Processes AI Policy
Use of the Contract Laboratory website constitutes acceptance of our Terms & Conditions